메뉴 건너뛰기




Volumn 17, Issue 3, 2009, Pages 1193-1206

Discovery of N-[(1R,2S,5S)-2-{[(5-chloroindol-2-yl)carbonyl]amino}-5-(dimethylcarbamoyl)cyclohexyl]-5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamide hydrochloride: A novel, potent and orally active direct inhibitor of factor Xa

Author keywords

Anticoagulant; Factor Xa inhibitors; Lipophilicity; Non amidino compound; Oral bioavailability; Protein binding

Indexed keywords

1,2 DIAMINOCYCLOHEXANE; 2 [4 [(1 ACETIMIDOYL 3 PYRROLIDINYL)OXY]PHENYL] 3 (7 AMIDINO 2 NAPHTHYL)PROPIONIC ACID; [2 [[(5 CHLOROINDOL 2 YL)CARBONYL]AMINO] 5 (DIMETHYLCARBAMOYL)CYCLOHEXYL] 5 METHYL 4,5,6,7 TETRAHYDROTHIAZOLO[5,4 C]PYRIDINE 2 CARBOXAMIDE; BLOOD CLOTTING FACTOR 10A INHIBITOR; PYRROLIDINE DERIVATIVE; UNCLASSIFIED DRUG;

EID: 58949103808     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2008.12.037     Document Type: Article
Times cited : (41)

References (26)
  • 21
    • 58949098554 scopus 로고    scopus 로고
    • This discovery was presented in part at 234th National Meeting of the American Chemical Society, Boston, MA, August 19-23, 2007, MEDI-76.
    • This discovery was presented in part at 234th National Meeting of the American Chemical Society, Boston, MA, August 19-23, 2007, MEDI-76.
  • 22
    • 58949089680 scopus 로고    scopus 로고
    • 26th Medicinal Chemistry Symposium, Kanagawa, Japan, November 28-30, 2007, 2P-20.
    • 26th Medicinal Chemistry Symposium, Kanagawa, Japan, November 28-30, 2007, 2P-20.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.